You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Bax/Bcl-2 Cascade Is Regulated by the EGFR Pathway: Therapeutic Targeting of Non-Small Cell Lung Cancer
|
|---|---|
| Published in |
Frontiers in oncology, March 2022
|
| DOI | 10.3389/fonc.2022.869672 |
| Pubmed ID | |
| Authors |
Manzar Alam, Shoaib Alam, Anas Shamsi, Mohd Adnan, Abdelbaset Mohamed Elasbali, Waleed Abu Al-Soud, Mousa Alreshidi, Yousef MohammedRabaa Hawsawi, Anitha Tippana, Visweswara Rao Pasupuleti, Imtaiyaz Hassan |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 1 | 25% |
| Unknown | 3 | 75% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 75% |
| Scientists | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 40 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 3 | 8% |
| Unspecified | 2 | 5% |
| Professor | 2 | 5% |
| Student > Bachelor | 2 | 5% |
| Student > Ph. D. Student | 2 | 5% |
| Other | 6 | 15% |
| Unknown | 23 | 57% |
| Readers by discipline | Count | As % |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 13% |
| Biochemistry, Genetics and Molecular Biology | 4 | 10% |
| Unspecified | 2 | 5% |
| Computer Science | 1 | 3% |
| Agricultural and Biological Sciences | 1 | 3% |
| Other | 1 | 3% |
| Unknown | 26 | 65% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 April 2022.
All research outputs
#14,853,515
of 25,478,886 outputs
Outputs from Frontiers in oncology
#4,067
of 22,568 outputs
Outputs of similar age
#196,752
of 446,243 outputs
Outputs of similar age from Frontiers in oncology
#261
of 1,520 outputs
Altmetric has tracked 25,478,886 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,568 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 446,243 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.
We're also able to compare this research output to 1,520 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.